| 000 | 01539 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513151656.0 | ||
| 264 | 0 | _c19980925 | |
| 008 | 199809s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.317.7159.621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKristiansen, B E | |
| 245 | 0 | 0 |
_aWhich contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cSep 1998 |
||
| 300 |
_a621-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xtherapeutic use |
| 650 | 0 | 4 |
_aCarrier State _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aContact Tracing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xisolation & purification |
| 650 | 0 | 4 |
_aNorway _xepidemiology |
| 650 | 0 | 4 |
_aPharynx _xmicrobiology |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 700 | 1 | _aTveten, Y | |
| 700 | 1 | _aJenkins, A | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 317 _gno. 7159 _gp. 621-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.317.7159.621 _zAvailable from publisher's website |
| 999 |
_c9693180 _d9693180 |
||